Smoking-related bladder cancer burden from 1990 to 2021: An age-period-cohort analysis of the global burden of disease study

Introduction Bladder cancer is common in the elderly, with smoking as a major risk factor. This study assesses the global burden of bladder cancer attributable to smoking, using data from 204 countries and regions (1990–2021). Methods Mortality, age-standardized mortality rates (ASMR), disability-a...

Full description

Saved in:
Bibliographic Details
Main Authors: Qingqing Yu, Bing Li, Hao Lin, Chao Sun, Xinyue Yang, Zhiqiang Zhang
Format: Article
Language:English
Published: European Publishing 2025-06-01
Series:Tobacco Induced Diseases
Subjects:
Online Access:https://www.tobaccoinduceddiseases.org/Smoking-related-bladder-cancer-burden-from-1990-to-2021-An-age-period-cohort-analysis,204744,0,2.html
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Introduction Bladder cancer is common in the elderly, with smoking as a major risk factor. This study assesses the global burden of bladder cancer attributable to smoking, using data from 204 countries and regions (1990–2021). Methods Mortality, age-standardized mortality rates (ASMR), disability-adjusted life years (DALYs), and age-standardized DALY rates (ASDR) were extracted from the Global Burden of Disease (GBD) 2021 study. The burden of smoking-related bladder cancer was analyzed by age, gender, and sociodemographic index (SDI). Results Between 1990 and 2021, global deaths due to smoking-related bladder cancer increased by 42.9%, while disability rose by 31.0%. In 2021, the global number of bladder cancer deaths due to smoking reached 58766 (95% UI: 49381– 70891). Despite these increases, both ASMR and ASDR declined globally. Males experienced a higher increase in mortality and disability, with rates approximately 10 times higher than females. Middle SDI countries saw the largest rise in burden. The annual decline in mortality was 2.06%, greater in males than females. Conclusions The burden of smoking-related bladder cancer is higher in males, middle-aged and elderly individuals, and medium to high SDI countries. Targeted prevention and health policies are crucial to reducing the disease’s impact on populations and healthcare systems.
ISSN:1617-9625